
A panel of outside advisers to the U.S. Food and Drug Administration is expected to endorse emergency use of Moderna Inc.'s coronavirus vaccine during a meeting on Thursday, as the nation prepares to roll out a second vaccine.
from CBC | Health News https://ift.tt/2WngAxg
Aucun commentaire:
Enregistrer un commentaire